BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3317029)

  • 1. Epidemiology in protection and prevention against environmental mutagens/carcinogens. Examples from occupational medicine.
    Forni A; Bertazzi PA
    Mutat Res; 1987 Dec; 181(2):289-97. PubMed ID: 3317029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of human populations for mutations induced by environmental pollutants: use of human lymphocyte system.
    Natarajan AT; Obe G
    Ecotoxicol Environ Saf; 1980 Dec; 4(4):468-81. PubMed ID: 7009142
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological indicators of genotoxic risk and metabolic polymorphisms.
    Pavanello S; Clonfero E
    Mutat Res; 2000 Oct; 463(3):285-308. PubMed ID: 11018745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach.
    Kopjar N; Garaj-Vrhovac V; Kasuba V; Rozgaj R; Ramić S; Pavlica V; Zeljezić D
    Int J Hyg Environ Health; 2009 Jul; 212(4):414-31. PubMed ID: 19049854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational exposure to anticancer drug--potential and real hazards.
    Sorsa M; Hemminki K; Vainio H
    Mutat Res; 1985 Sep; 154(2):135-49. PubMed ID: 3929080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of human exposure to occupational genotoxicants.
    Rossner P; Cerna M; Bavorova H; Pastorkova A; Ocadlikova D
    Cent Eur J Public Health; 1995 Nov; 3(4):219-23. PubMed ID: 8903525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatics as hazardous chemicals in healthcare workers' environment.
    Pałaszewska-Tkacz A; Czerczak S; Konieczko K; Kupczewska-Dobecka M
    Int J Occup Med Environ Health; 2019 Apr; 32(2):141-159. PubMed ID: 30896680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Theory and practice of primary cancer prevention].
    Tompa A
    Magy Onkol; 2007; 51(1):7-21. PubMed ID: 17417671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage.
    Mutat Res; 1990 Jul; 241(3):325-37. PubMed ID: 2366811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic monitoring of industrial populations potentially exposed to genotoxic chemicals and of control populations.
    de Jong G; van Sittert NJ; Natarajan AT
    Mutat Res; 1988 Mar; 204(3):451-64. PubMed ID: 3347216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tabulation and assessment of 113 human surveillance cytogenetic studies conducted between 1965 and 1984.
    Ashby J; Richardson CR
    Mutat Res; 1985 Sep; 154(2):111-33. PubMed ID: 4033683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic indicators of genotoxicity in subjects occupationally exposed to antineoplastic drugs].
    Forni A; Bonatti S; Merler E
    Med Lav; 1996; 87(3):222-9. PubMed ID: 8965735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New markers for monitoring occupational cancer: the example of oncogene proteins.
    Brandt-Rauf PW
    J Occup Med; 1988 May; 30(5):399-404. PubMed ID: 3286845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed to cytostatic drugs.
    Rössner P; Cerná M; Pokorná D; Hájek V; Petr J
    Mutat Res; 1988 Jul; 208(3-4):149-53. PubMed ID: 3398866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher plant assays for the detection of chromosomal aberrations and gene mutations-a brief historical background on their use for screening and monitoring environmental chemicals.
    Grant WF
    Mutat Res; 1999 May; 426(2):107-12. PubMed ID: 10350580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods of Classical and Molecular Cytogenetics Suitable for Biodosimetry of Persons with Professional Exposure to Carcinogens.
    Petrovová M; Svoboda M
    Klin Onkol; 2019; 32(4):270-276. PubMed ID: 31426642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.